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ABSTRACT
INTRODUCTION: Acute coronary syndrome (ACS) is a common cause of mortality and morbidity. An ACS 
diagnosis can be made with electrocardiogram (ECG) and cardiac markers. However, despite medical ad-
vances, 2–5% of ACS patients are undiagnosed and discharged from emergency departments (EDs) because 
clinicians often find it difficult not only to diagnose and treat high-risk patients but also to define nonemer-
gency diseases or safely discharge healthy patients. Risk stratification can be prevented, and inappropriate 
diagnosis and treatment protocols can be identified. The ED Assessment of Chest Pain Score-Accelerated Di-
agnostic Protocol (EDACS-ADP) scoring system, developed to identify patients with chest pain but at low risk 
for a major adverse cardiac event (MACE), is the first score based on clinical data from emergency medicine. 
AIM: This study investigates the usability of EDACS-ADP in Turkey.
MATERIAL AND METHODS: This is a prospective observational study of 392 patients. The primary outcome 
was a major adverse cardiovascular event (MACE) within thirty days. 
RESULTS: A total of 116 MACEs occurred in 65 (16,6%) patients during a one-month follow-up. The sensitivi-
ty, specificity,  positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (+ LR), 
and negative likelihood ratio (–LR) values of the EDACS-ADP score for the evaluation of 30-day MACE rate in 
patients who admitted with chest pain for two months were as follows: 96.9%, 64.5%, 35.2%, 99.1%, + LR: 
2.73, and –LR: 0.05. 
CONCLUSIONS: Most of these patients were classified by the EDACS-ADP as low risk and suitable for dis-
charge. The 30-day MACE rate of development was significantly low (0.9%) and acceptable in patients 
grouped as low risk.
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INTRODUCTION
Chest pain is one of the most common complaints 
worldwide, requiring rapid, accurate diagnosis and 
evaluation. In 3% to 6% of all emergency admis-
sions, the only complaint is chest pain [1]. In the 
United States (U.S.), emergency services garner 
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8–10 million visits per year due to chest pain, which 
is the second most common cause of admission 
and the number of annual ED visits is increasing 
[2-4]. Chest pain may be caused by non-life-threat-
ening factors such as myalgia or by severe causes 
such as aortic dissection or pulmonary embolism. 
Although an ED evaluation usually focuses on seri-
ous pathologies, the last diagnoses in most patients 
are non-life-threatening causes. Acute coronary 
syndrome (ACS), pulmonary embolism, and aor-
tic dissection are diagnosed in 12,5% of patients 
presenting to the ED with chest pain or discharged 
from the hospital after evaluation [5]. ACS, which 
is most commonly associated with chest pain, is 
a common cause of mortality and morbidity today. 
The diagnosis of ACS can be made by using ECG and 
cardiac markers; however, normal ECG and cardiac 
data do not mean the disease does not exist. Despite 
all the advances in medicine, 2–5% of patients with 
acute myocardial infarction (MI) are discharged from 
the ED without being diagnosed. These “missed 
MI” cases account for 40% of emergency service 
malpractice cases [6, 7].
For these reasons, when patients who have chest 
pain are evaluated in the ED, clinicians often find 
it difficult not only to diagnose and treat high-risk 
patients but also to identify non-emergency diseases 
or safely discharge those who have no disease. [8]. 
In patients who have chest pain, risk stratification 
can be prevented, and unnecessary diagnosis and 
treatment protocols can be identified. Also, low-
risk patients can be discharged from the ED quickly, 
reducing overcrowding and health costs [8, 9]. In 
contrast, the correct diagnosis of high-risk patients 
prevents premature discharge and allows these pa-
tients to be observed for longer times with all the 
facilities. For this reason, most current publications 
and guidelines recommend the use of a risk scoring 
system for patients presenting to the ED with chest 
pain [8, 10]. There are many scoring systems for 
evaluation of patients with chest pain or ACS, but 
most of them are designed to predict the potential 
for adverse events in patients undergoing intensive 
care or to distinguish patients at high risk from 
those with diagnosed ACS. Very few scoring sys-
tems are used for identifying low- to moderate-risk 
patients who may be discharged among those who 
present to the ED with chest pain [8, 9]. 
The ED Assessment of Chest Pain Score-Accel-
erated Diagnostic Protocol (EDACS-ADP) scoring 
system, which was developed to identify chest pain 
patients with a low risk for MACE, is the first system 
based on clinical data from emergency medicine 
[9, 11]. The EDACS-ADP was created in 2014 by 
Than et al. [12], using information from patients 
who participated in the ADAPT study, and later val-
idated in Australia and New Zealand, where it was 
developed. Researchers focused on two goals in 
developing the scoring system. The first goal was to 
develop a clinically reasonable score to predict the 
short-term risk of MACEs in adults presenting to the 
ED with a complaint of angina. The second aim was 
to accurately identify the low-risk group for MACE 
and to safely and quickly discharge them. Therefore, 
researchers developed the EDACS using a troponin 
assay and an ECG at the second hour and an accel-
erated diagnostic protocol (ADP) feature [12]. The 
EDACS-ADP can correctly classify more than half of 
those admitted to the ED with chest pain (51%) as 
low risk for MACE, allowing for early discharge. The 
rate of MACE development at the end of the thirty 
days after early discharge was 0.3% [8, 9]. Since its 
development, the EDACS-ADP has been validated 
by many prospective and retrospective studies in 
different countries. This study aims to investigate the 
usability of the EDACS-ADP scoring system as a risk 
stratification tool in Turkey. 
MATERIAL AND METHODS
Study design and setting
This is a prospective observational study carried 
out on patients coming to the Ataturk Universi-
ty Hospital Emergency Medicine Clinic between 
2/1/2017 and 3/31/2017. The diagnosis, treatment, 
and management of the patients included in the 
study progressed completely in accordance with 
the chest pain and ACS procedures in the hospi-
tal, and the discharge decision was made following 
these same procedures. The study was conducted 
independently of these protocols, and only the sec-
ond-hour troponin value was measured from pa-
tients evaluated and recommended by a physician. 
Study population
The Ataturk University Hospital is a third-step pub-
lic hospital. Located in Erzurum in Turkey it is the 
largest hospital in this province and operates an 
advanced diagnosis and treatment center for twelve 
provinces in its immediate vicinity. Approximately 
120,000 patients are admitted to its ED annually, 
either by ambulance (112) or referral from hospitals 
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in the surrounding provinces and districts. The hos-
pital has a 24-hour coronary angiography laboratory 
with a team that is on-call during working hours and 
experienced in percutaneous coronary intervention 
(PCI). The dedicated biochemical laboratory for ED 
patients provides uninterrupted service throughout 
the day. 
Patients over 18 years of age who were ad-
mitted to the ED with chest pain for more than 
five minutes and who read the consent form and 
agreed to participate were included in the study. The 
study included the troponin measurements taken 
in the ED. In the presence of any of the following 
criteria, the patient was excluded from the study: 
i. patients under the age of 18 years, ii. those who 
did not agree to participate in the study, iii. pa-
tients diagnosed with a certain reason for chest 
pain after initial examination without the need for 
further imaging and laboratory examination (e.g., 
thoracic wall pathologies, costochondritis, fibromy-
algia, mastalgia, etc.), iv. patients with noncoronary 
pathologies as the cause of chest pain after imaging 
and laboratory tests (pneumonia, pulmonary embo-
lism, pneumothorax, pericarditis, myocarditis, aortic 
dissection, GIS-induced pathologies), v. patients pre-
senting with trauma-induced chest pain, vi. patients 
who did not think a cardiac test and follow-up 
necessary, vii. patients diagnosed with ST-segment 
elevation myocardial infraction (STEMI), viii. patients 
who were involved in the study before, ix. patients 
who did not have access to medical records, or who 
could not be reached after 30 days of follow-up, or 
who died due to cardiovascular reasons during the 
follow-up period, and x. patients developing cardiac 
arrest during evaluation in the ED.
Data collection
To record the patients’ information, a study form 
was prepared in advance. This form was filled out by 
the study physician, who was not the patients’ pri-
mary physician, by using the face-to-face interview 
method after evaluating patients in the emergency 
room, before the discharge or admission decision 
was made. Thus, the researchers were prevented 
from bias, and the study did not hinder the medical 
evaluation. A one-hour coordination and training 
meeting was held with the physicians who were 
likely to fill out the study form. Clinical symptoms 
and medical history were obtained by asking the 
patient directly, regardless of the medical records 
of the patient. If the patient was not sure of the 
answer (e.g., a history of hypertension), the answer 
was marked as “No.”
Calculation of the EDACS-ADp
More than three risk factors were identified for those 
aged 18 to 50 years: family history of premature cor-
onary artery disease (CAD), dyslipidemia, diabetes, 
hypertension, current smoker, or history of seven 
heart diseases. Each of the variables has different 
negative or positive values according to its weight, 
and the total score is obtained by summing the val-
ues of the variables. The score of the two variables 
is negative, that is, when the scores of these precur-
sors are collected, they are mathematically extract-
ed from the total score. The result gives a patient 
score between -10 and 34. EDACS values above 
16 indicate a high risk of MACE [10, 12, 13]. Table 1 
shows the EDACS-ADP and the scores obtained 
from the variables [12]. If the EDACS is < 16 for 
a patient, if there is no new ischemic change in the 
ECG, and if both troponin values in the second hour 
are negative, this patient is considered low risk. Pa-
tients in this group may be discharged early in the 
outpatient period [12]. If the EDACS is > 16, or the 
ECG shows new ischemic changes, or if any of the 
troponin values are positive at the time of arrival or 
by the second hour, these patients are considered 
middle or high risk. If the initial troponin values are 
not taken, a delayed troponin test is performed [10]. 
For the EDACS, 16 is chosen as a cutoff because it 
maintains a sensitivity of 99% for MACE, while its 
specificity is maximum [10].
The patients’ EDACS scores were calculated af-
ter discharge. Following the methodology for the 
EDACS-ADP derivation, a variable was considered 
normal or negative when calculating points during 
the study. In this way, while the study’s reliability 
was maintained, the sensitivity was kept at the low-
est obtained value, and, if the missing data were 
considered abnormal or positive, it was assumed 
that the sensitivity and specificity of the study would 
decrease [13].
ECG evaluation
When a patient was admitted to the ED with chest 
pain, an ECG was performed within the first five 
minutes according to protocol. A copy of this ECG 
was kept with the study form and these results were 
evaluated in terms of new ischemia by two emer-
gency physicians. If there was a difference between 
the physicians’ ECG interpretations, a third blinded 
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physician made the final decision. The ECGs of the 
patients included in the study were considered to 
have new ischemia in the presence of at least one 
of the following changes: i. at least 0.05 millivolt 
(mV) ST-segment depression in two or more adjacent 
leads and T wave inversion at a depth of ii. 0.1 mV or 
more (negativity), iii. a Q wave presence longer than 
30 milliseconds and greater than 0.1 mV, ≥ 0.2 mV 
for leads V1, V2, V3 from iv. J point, an ST-segment 
height in at least two adjacent leads with a size 
of  ≥ 0.1 mV, or v. a new left bundle branch block. 
These changes were considered as old changes if 
present in the patient’s old ECG or medical records. 
If there were no records to prove that the chang-
es were old, they were evaluated as new ischemic 
changes. Data from the validation study of Flaws et 
al. [13] were taken as examples for this evaluation.
Evaluation of troponin results
The first troponin assay was done in the emergency 
room, and a second-hour troponin assay was per-
formed on patients that the doctor was considering 
following. The serum troponin measurements were 
performed using a DXI 800 Beckman Coulter (U.S.) 
instrument. A troponin measurement of 0.04 mi-
crogram / L, which is the 99th percentile and above 
the reference limit, was accepted as the clinical 
threshold in determining myocardial injury during 
the study period. The EDACS-ADP was classified as 
high risk if there were values above this limit in the 
troponin measurements at the first or second. 
Key outcome measures
The primary outcome was MACE. MACE development 
information was investigated by phone call and/or by 
examining the hospital records thirty days after the 
patient’s discharge. If any of the following conditions 
developed over the thirty days, MACE formation was 
considered positive: i. acute MI (STEMI and NSTEMI), 
ii. emergency revascularization requirement, iii. car-
diovascular death, iv. cardiogenic shock, or v. high-
grade atrioventricular block or ventricular arrhythmia 
requiring access. Coronary artery bypass graft (CABG), 
stenting of the coronary artery, and other PCIs were 
considered as the necessity for emergency revascular-
ization. MACE development was evaluated as positive 
in a patient who was admitted with chest pain after 
discharge from the hospital, not after discharge or 
hospitalization. For this reason, it was assumed that 
all NSTEMI patients developed MACE directly.
Statistical analysis
The SPSS 20.0 statistical software package was 
used for statistical analysis. Values were given 
with frequency, percentage, mean, and standard 
deviation. Pearson’s Chi-square and Fisher’s exact 
test were used to interpret the data. A Kolmogor-
ov-Smirnov distribution test was used to examine 
the normal distribution, and a Mann-Whitney U test 
was used to compare the parameters between 
groups. Sensitivity, specificity, positive predictive val-
ue (PPV), and negative predictive value (NPV) were 
Table 1. EDACS-ADP variables, variable points, and 
























Between 18 and 50 years old 
i. Known coronary artery disease*
ii. More than three risk factors**
+4
Sweating (diaphoresis) +3
Pain radiates to the arm or 
shoulder
+5
Pain occurred or worsened by 
inspiration
–4
Pain reproduced by palpation –6
Low-risk patient All criteria must be 
provided
1. EDACS < 16
2. No new ischemia in 
the ECG
3. Negative series of 
troponin
Risky patient The existence of any 
criteria is sufficient
1. EDACS > 16
2. The presence of new 
ischemia in the ECG
3. Positive series of 
troponin
ADP — accelerated diagnostic protocol; ECG — electrocardiography; EDACS — Emer-
gency Department Assessment of Chest Pain Score-Accelerated Diagnostic Protocol 
* Known coronary artery disease: a history of previous acute myocardial infarction, past 
coronary artery bypass graft surgery, previous coronary percutaneous intervention.  
** Risk factors: family history of premature CAD, dyslipidemia, diabetes, hypertension, 
current smoker.
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calculated according to the cutoff value. Results 
were evaluated at a 95% confidence interval and 
a significance level of p < 0.05.
RESULTS
A total of 18,597 patients were admitted to the 
ED. Chest pain was the most common reason for 
1004 (5.4%) of these patients. Of these 1004 pa-
tients, 612 were excluded from the study due to 
various reasons, 206 patients refused to participate 
in the study, and 107 patients with chest pain com-
plaints were discharged from the ED without any 
investigation after the first examination and were not 
included in the study. In this group of patients, the 
diagnosis was mostly chest wall pathologies. Since 
54 patients were diagnosed with STEMI after the first 
ECG because of trauma-related chest pain, 146 pa-
tients were excluded due to the lack of troponin in 
the second hour after the clinician did not see the 
need for cardiac testing and follow-up. Seventeen 
of the patients had more than one visit with com-
plaints of chest pain during the study period. The 
first applications of these patients were taken into 
consideration, while the other applications were ex-
cluded from the study. Two patients who developed 
cardiac arrest during ED evaluation were excluded 
from the study. Some of the patients were diagnosed 
with the non-coronary disease by laboratory and im-
aging tests. Seven of these patients were diagnosed 
with pneumonia, three with pulmonary thromboem-
bolism, two with spontaneous pneumothorax, and 
two with myocarditis. One patient was diagnosed 
with pancreatitis, pericarditis, and aortic dissection 
despite chest pain. A total of 17 patients were ex-
cluded from the study. After 30 days of follow-up, 
52 patients were excluded from the study. The study 
was completed with 392 patients (Figure 1).
Of the 392 patients who completed the study, 
69.6% (n = 273) were male, and 30.4% (n = 119) 
were female. The mean age of the patients was 
49.6 ± 17.4 years (min: 18, max: 83). The vital signs 
of the patients included in the study are shown in 
Table 2, and their medical histories and cardiovas-
cular risk factors are shown in Table 3. The median 
time after the onset of the patients’ complaints 
was 240 minutes (IQR1: 120 min, IQR3: 900 min). 
There were new ischemic changes in the ECG of 
52 (13.3%) patients. The arrival and second-hour 
troponin values of the patients who participated in 
the study were recorded and evaluated. The median 
value of arrival troponin was 0.00 mcg/L (IQR1: 0.00, 
IQR3: 0.006, minimum: 0, maximum; 16.71 mcg/L, 
mean: 0.27mcg/L ± 1.45); the median value was 
0.00 mcg/L (IQR1: 0.00, IQR3: 0.007, minimum: 0, 
maximum: 24.23, mean value: 0.32 mcg/L ± 1.80). 
fIGURE 1. Patient flow chart 
ED — Emergency Department; STEMI — ST-segment elevation 
myocardial infraction
Table 2. Vital findings of the patients included in 
the study








80.91 ± 14.89 41 136
Respiration 
[breaths/min]
16.42 ± 3.38 8 31
Temperature [°C] 36.58 ± 0.41 35.4 39
Fingertip oxygen 
saturation [%]
95 ± 3.41 81 100
SD — standard deviation
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NSTEMI was diagnosed in 14.3% (n = 56) of the 
patients, USAP in 8.9% (n = 35), and nonspecific 
chest pain in 76.8% (n = 301).
A total of 116 MACEs developed in 65 (16.6%) 
of all patients included in the study during a one-
month follow-up. Of these 65 patients, 8 (12.3%) 
underwent PCI without troponin elevation (without 
MI). In 13 (20%), MACE was caused by NSTEMI 
alone, and no interventional procedures were per-
formed. NSTEMI and PCI were associated with 
37 (56.9%) patients. NSTEMI, PCI, and CABG were 
observed in 4 (6.2%) patients, and NSTEMI, PCI, 
and high-grade atrioventricular (AV) block were 
observed in the remaining 3 patients (4.6%). The 
distribution of patients according to MACE causes 
is shown in Table 4. NSTEMIs included in the MACE 
group were diagnosed in the ED. No patients de-
veloped MI after discharge. Of the patients who 
developed MACE, 59 were admitted to the car-
diology clinic in the first ED. In 6 patients, MACE 
developed after discharge from the ED. While 81.5% 
of MACE patients were men, only 18.5% were 
women. This difference was statistically significant 
(p = 0.022 < 0.05). The mean age of the patients 
who did not develop MACE was 46.78 ± 16.98, 
and the mean age of patients who did develop 
MACE was 63.93 ± 11.95 years, and this value was 
statistically significant (p = 0.000 < 0.05).
Of the patients included in the study, 64% 
(n = 251) had an EDACS of < 16, while 36% 
(n = 141) had an EDACS > = 16. Further, 54.3% 
(n = 213) of the patients were classified as low risk 
according to the EDACS-ADP, and 45.7% (n = 179) 
were high risk. The frequencies of the EDACS deter-
minants are shown in Table 5. MACE developed in 
0.9% (n = 2) of the low-risk patients, while MACE 
developed in 35.2% (n = 63) of the high-risk pa-
tients (p = 0.000). According to these results, the 
sensitivity, specificity, PPV, NPV, + LR, and –LR val-
ues of the EDACS-ADP for the thirty day evaluation 
of MACE in patients who presented to the study 
clinic with chest pain for two months were as fol-
Table 4. Distribution of patients with MACE
MACE Reason Patient No. (%)
PCI (No MI) 8 (12.3%)
NSTEMI 13 (20%)
NSTEMI, PCI 37 (56.9%)
NSTEMI, PCI, CABG 4 (6.2%)
NSTEMI, PCI, CABG, high-grade AV block 3 (4.6%)
Total 65 (100%)
MACE — major adverse cardiac event; PCI — percutaneous coronary intervention;  
MI — myocardial infarction; NSTEMI — non-ST-segment elevation myocardial infraction; 
CABG — coronary artery bypass graft; AV — atrioventricular
Table 5. Frequency of EDACS determinants
































Male gender 6 273 (69.6%)
From 18–50 years old and
I. Known coronary artery disease
or
II. More than three risk factors
4 29 (7.4%)
Symptoms and findings
Sweating 3 130 (33.2%)
Pain radiates to the arm or shoulder 5 181 (46.2%)
Pain occurred or worsened by 
inspiration
–4 105 (26.8%)
Pain reproduced by palpation –6 52 (13.3%)
EDACS
< 16 251 (64%)
> = 16 141 (36%)
EDACS — Emergency Department Assessment of Chest Pain Score-Accelerated Diag-
nostic Protocol; n — number
Table 3. Medical history of patients and 
cardiovascular risk factors
n (%)
Known coronary artery disease 79 (20.2%)
COPD 28 (7.1%)
Heart failure 25 (6.4%)
Passed PKG 130 (33.2%)





Early coronary artery disease in the family 54 (13.8%)
COPD — chronic obstructive pulmonary disease; PKG — protein kinase G;  
CABG — coronary artery bypass graft; n — number
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lows: 96.9% (95% CI 89,3–99.6%), 64.5% (95% CI 
59.1–69,7%), 35,2% (95% CI 28,2–42,7%), 
99,1% (95% CI 96.6–99.9%), +LR 2,73 (95% CI 
2.35–3.18), and –LR 0,05 (95% CI 0.01–0.19).
DISCUSSION
To the best of the authors’ knowledge, this is the 
first study conducted in Turkey on the EDACS-ADP 
system and one of the very few prospective studies 
on the EDACS-ADP in the world. Although there is 
no accepted consensus among clinicians on the rates 
of missed cases of MACE, many people think that 
a successful accelerated discharge protocol (ADP) 
should result in a MACE value of <1% in patients 
diagnosed as low risk. This performance would cor-
respond to an NPV of 99% [11, 14]. In the present-
ed study, the rate of missed cases among low-risk 
patients was 0.9% and the NPV value of the whole 
study population was 99.1%. In this regard, the use 
of the EDACS-ADP scoring system provides highly 
acceptable results in the population in which the au-
thors are working. The rate of development of MACE 
was 16.6% in the study patient group. The rate was 
6% in the study of Stopyra et al., 10.4% in Flaws et 
al., 15.4% in the derivation cohort, and 12.9% in the 
study of Than et al. [11–13]. Looking at MACE rates, 
the study patient cohort can be said to be at a higher 
risk, most likely because the study clinic is a part of 
the largest and best-equipped hospital in the area 
and therefore can accept more risky patients.
In the presented study, 54.3% of the patients 
were classified as low risk. In the EDACS-ADP deriva-
tion cohort and subsequent validation studies, this 
rate ranged from 41.2% to 66.7% [11–13]. In stud-
ies comparing the chest pain scores in previous emer-
gency services, the EDACS-ADP is one of the best-rat-
ed scoring systems [15]. In the presented study, if the 
authors included patients with an EDACS of 12 or 
higher in the high-risk group, 41.3% (n = 162) of all 
patients would be in the low-risk group. In this case, 
no MACE would have occurred in the low-risk group. 
Thus, the sensitivity of the test would reach 100%, 
and its specificity would decrease to 49.5% with PPV 
and NPV values of 28.2% and 100%, respectively. 
This increases the power of the test for MACE esti-
mation and reduces the rate of missed MACEs. Even 
though the EDACS-ADP system decreased the EDACS 
score to 12, making the EDACS-ADP more problem-
atic to use for determining discharge, the EDACS-
ADP allowed the decision to discharge more patients 
than many ADP tests under these conditions.
In the presented study, the authors found the 
EDACS-ADP concentrations to be 96.9%, while in 
previous studies, this ratio ranged from 88.2% to 
100% [11–13]. In their validation study in the U.S., 
Stopyra et al. [11] found this to be lower (88.2%) 
than other studies and explained this as a result of 
the differences between the U.S. health system and 
that of other countries such as the more frequent 
use of angiography in the U.S. People in Turkey have 
a much higher rate of health insurance than in oth-
er parts of the world (98.6%) [16], and as a result, 
physicians can easily be found to perform interven-
tional procedures. This may explain the relatively low 
sensitivity value found in this study.
The troponin kit used in this study was not highly 
sensitive. This raises the question of whether the 
use of high-sensitivity troponin alone will alter the 
diagnostic accuracy of the existing rules. However, 
unlike the original derivation and validation study 
using high-steroidal troponin, previous studies using 
traditional troponin did not look at the diagnostic 
performance of EDACS-ADP [13].
Limitations
the study results may not be generalizable as this 
study was conducted in a single academic centre, 
for only two months, and with relatively small sam-
ple size. The main criterion for inclusion was the 
presence of chest pain, which would exclude some 
patients with atypical symptoms, such as fatigue, 
nausea, and dyspnea but no chest pain. In this 
study, the EDACS-ADP could not be used to exclude 
conditions such as pulmonary embolism or aortic 
dissection, which are rare but fatal causes of chest 
pain. The patient’s 30-day MACE development was 
obtained by querying the patient or looking at the 
medical records, and if the medical records could 
not be accessed, the MACE status had to be ob-
tained by phone. Although the assumption that the 
use of the EDACS-ADP system reduces hospital stays 
and decreases patient costs is theoretically correct, 
the cost analyses to prove this claim have not yet 
been done. Additional scientific data are needed to 
verify that patients have better outcomes when phy-
sicians use the EDACS-ADP method for differentiat-
ing chest pain causes than with current protocols.
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CONCLUSIONS
Most of the patients who presented to the study 
clinic with chest pain were classified by the EDACS-
ADP score as low risk and suitable for discharge. 
The 30-day MACE rate of development was sig-
nificantly low (0.9%) in patients identified as the 
low-risk group and was acceptable. Therefore, this 
study showed that the EDACS-ADP scoring system 
as applied in a region different from previous study 
centres had comparable efficacy and safety.
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